.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Queensland Health
US Army
QuintilesIMS
US Department of Justice
Covington
Boehringer Ingelheim
Argus Health
Chinese Patent Office
Healthtrust

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,078,020

« Back to Dashboard

Which drugs does patent 7,078,020 protect, and when does it expire?


Patent 7,078,020 protects ADASUVE and is included in one NDA.

This patent has one hundred and ninety-five patent family members in nineteen countries.

Summary for Patent: 7,078,020

Title:Delivery of antipsychotics through an inhalation route
Abstract: The present invention relates to the delivery of antipsychotics through an inhalation route. Specifically, it relates to aerosols containing antipsychotics that are used in inhalation therapy. In a method aspect of the present invention, an antipsychotic is delivered to a patient through an inhalation route. The method comprises: a) heating a composition, wherein the composition comprises an antipsychotic, to form a vapor; and, b) allowing the vapor to cool, thereby forming a condensation aerosol comprising particles with less than 5% antipsychotic drug degradation products. In a kit aspect of the present invention, a kit for delivering an antipsychotic through an inhalation route is provided which comprises: a) a thin coating of an antipsychotic composition and b) a device for dispensing said thin coating as a condensation aerosol.
Inventor(s): Rabinowitz; Joshua D. (Mountain View, CA), Zaffaroni; Alejandro C. (Atherton, CA)
Assignee: Alexza Pharmaceuticals, Inc. (Palo Alto, CA)
Application Number:10/750,303
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galen Uk ADASUVEloxapinePOWDER;INHALATION022549-001Dec 21, 2012RXYesYes► Subscribe► SubscribeYADASUVE IS A TYPICAL ANTIPSYCHOTIC INDICATED FOR THE ACUTE TREATMENT OF AGITATION ASSOCIATED WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER IN ADULTS► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 7,078,020

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,468,179Delivery of opioids through an inhalation route► Subscribe
8,955,512Method of forming an aerosol for inhalation delivery► Subscribe
7,060,255Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route► Subscribe
6,994,843Delivery of stimulants through an inhalation route► Subscribe
7,942,147Aerosol forming device for use in inhalation therapy► Subscribe
7,060,254Delivery of antidepressants through an inhalation route► Subscribe
7,063,830Delivery of anti-migraine compounds through an inhalation route► Subscribe
7,070,761Delivery of nonsteroidal antiinflammatory drugs through an inhalation route► Subscribe
6,743,415 Delivery of anti-migraine compounds through an inhalation route► Subscribe
7,491,047Delivery of antihistamines through an inhalation route► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,078,020

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria365548► Subscribe
Austria401063► Subscribe
Austria401064► Subscribe
Austria404173► Subscribe
Austria404184► Subscribe
Austria406878► Subscribe
Austria415155► Subscribe
Austria418330► Subscribe
Austria418971► Subscribe
Austria425746► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
Federal Trade Commission
Dow
Teva
US Department of Justice
Medtronic
Boehringer Ingelheim
Cantor Fitzgerald
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot